# SILDENAFIL CITRATE
> **ANDA202503** · Abbreviated New Drug Application (Generic) · Sponsor: WATSON LABS INC · Approved 2012-11-06
## Drug
- **FDA Application Number:** ANDA202503
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** SILDENAFIL CITRATE
- **Generic name:** Sildenafil Citrate
- **Active ingredients:** SILDENAFIL CITRATE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** WATSON LABS INC
- **First approval:** 2012-11-06
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202503)
---
*AI Analytics · CC0 1.0*